Overall, these findings suggest that the strong effects of HA extract and L-NAME on the PI3K/Akt signaling pathway and downstream targets hold promise for developing novel therapeutic strategies against cancer, particularly for drug-resistant tumors. Here, AKT1 is linked to cancer.